FAScinate Therapeutics

FAScinate Therapeutics Inc. Submits Investigational New Drug (IND) Application for Phase 2 Clinical Studies of Company's New Parkinson's Disease Treatment Read Now >

Friday, November 5, 2021 / FAScinate Therapeutics